HomeHEPA • NASDAQ
Follow
Hepion Pharmaceuticals Inc
Previous close
$2.50
Day range
$2.42 - $2.53
Year range
$1.49 - $20.66
Market cap
10.80M USD
Avg Volume
84.27K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 10.66M | 25.98% |
Net income | -10.53M | -23.16% |
Net profit margin | — | — |
Earnings per share | -2.74 | -24.55% |
EBITDA | -10.65M | -26.02% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 19.28M | -67.40% |
Total assets | 25.00M | -64.13% |
Total liabilities | 8.84M | -15.27% |
Total equity | 16.16M | — |
Shares outstanding | 4.34M | — |
Price to book | 0.66 | — |
Return on assets | -86.70% | — |
Return on capital | -124.66% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -10.53M | -23.16% |
Cash from operations | -11.24M | 10.36% |
Cash from investing | 2.58K | — |
Cash from financing | — | — |
Net change in cash | -11.24M | 10.54% |
Free cash flow | -7.45M | 18.72% |
About
Founded
2013
Website
Employees
25